Device
Erchonia® FX-635™
Erchonia® FX-635™ is a medical device with 3 clinical trials. Historical success rate of 66.7%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
150%(3 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
terminated133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
terminatednot_applicable
An Evaluation of the Effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy Pain
NCT04006392
completednot_applicable
Study of Low Level Laser Therapy to Treat Diabetic Peripheral Neuropathy Foot Pain
NCT02461225
completednot_applicable
A Study to Evaluate the Effect of Low Level Laser Light on Low Back Pain
NCT02538523
Clinical Trials (3)
Showing 3 of 3 trials
NCT04006392Not Applicable
An Evaluation of the Effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy Pain
NCT02461225Not Applicable
Study of Low Level Laser Therapy to Treat Diabetic Peripheral Neuropathy Foot Pain
NCT02538523Not Applicable
A Study to Evaluate the Effect of Low Level Laser Light on Low Back Pain
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3